MedPath

Mcneil AB

Mcneil AB logo
🇸🇪Sweden
Ownership
Subsidiary
Established
1914-01-01
Employees
501
Market Cap
-
Website
http://www.mcneilab.se

Clinical Trials

49

Active:7
Completed:40

Trial Phases

6 Phases

Early Phase 1:1
Phase 1:19
Phase 2:2
+3 more phases

Drug Approvals

6

PHILIPPINES:2
SFDA:2
NMPA:1
+1 more agencies

Drug Approvals

Nicotine Chewing Gum

Product Name
力克雷
Approval Number
H20160589
Approval Date
Dec 29, 2018
NMPA

Clinical Trials

Distribution across different clinical trial phases (44 trials with phase data)• Click on a phase to view related trials

Phase 1
19 (43.2%)
Not Applicable
15 (34.1%)
Phase 4
4 (9.1%)
Phase 3
3 (6.8%)
Phase 2
2 (4.5%)
Early Phase 1
1 (2.3%)

A Study of Butamirate Citrate Syrup Versus (vs) Sinecod Syrup (Vanilla) in Adult Healthy Study Volunteers

Phase 1
Withdrawn
Conditions
Healthy
Interventions
First Posted Date
2022-01-10
Last Posted Date
2022-05-20
Lead Sponsor
McNeil AB
Registration Number
NCT05182047
Locations
🇷🇺

"Scientific and Research centre Eco-safety" Limited Liability Company, 65, Yuri Gagarin prospect, Saint -Petersburg, Russian Federation

A Study of Combination Caplet With Loperamide Hydrochloride and Simethicone, and Imodium Express Tablets-lyophilizate Coadministered With Espumisan Capsule in Healthy Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Combination Caplet with Loperamide HCl and Simethicone
First Posted Date
2019-12-05
Last Posted Date
2020-09-10
Lead Sponsor
McNeil AB
Target Recruit Count
48
Registration Number
NCT04186936
Locations
🇷🇺

"Scientific and Research centre Eco-safety" Limited Liability Company, Saint-Petersburg, Russian Federation

A Study to Assess Bioquivalence Between a Novel Naproxen Sodium 275 mg Film-coated Tablet and Nalgesin Naproxen Sodium 275 mg Film-coated Tablet in Healthy Adult Volunteers

First Posted Date
2018-10-05
Last Posted Date
2020-01-23
Lead Sponsor
McNeil AB
Target Recruit Count
28
Registration Number
NCT03697889
Locations
🇷🇺

LLC "Scientific and Research centre Eco-safety", St.Petersburg, Russian Federation

A Study to Compare Two Formulations of Xylometazoline/Dexpanthenol Nasal Spray for the Treatment of Nasal Congestion.

Phase 3
Completed
Conditions
Nasal Congestion
Interventions
Drug: xylo+dex nasal spray (0.1 mg+5 mg/dose)
Drug: Nasic
First Posted Date
2018-02-20
Last Posted Date
2018-10-18
Lead Sponsor
McNeil AB
Target Recruit Count
140
Registration Number
NCT03439436
Locations
🇷🇺

Railways clinical hospital n.a.Semashko at Lublino station JSC "RZD", Moscow, Russian Federation

🇷🇺

City Polyclinic #2, Moscow, Russian Federation

🇷🇺

First Moscow State Medical University n. a. I. M. Sechenov, Moscow, Russian Federation

and more 2 locations

A Study to Determine the Efficacy and Safety of a Benzocaine Lozenge for Treatment of Sore Throat.

Phase 3
Completed
Conditions
Sore Throat
Interventions
First Posted Date
2018-02-14
Last Posted Date
2018-10-18
Lead Sponsor
McNeil AB
Target Recruit Count
260
Registration Number
NCT03432923
Locations
🇷🇺

Railway Clinical Hospital n.a. N.A. Semashko Lyublino railway station of the Russian Railways, Stavropolskaya str., 23, build.1,, Moscow, Russian Federation

🇷🇺

City Clinical Hospital n.a. V.M. Buyanov Bakinskaya str., 26, Moscow, Russian Federation

🇷🇺

Central Clinical Hospital of Russian Academy of Sciences Litovskiy bulvar, 1A, Moscow, Russian Federation

and more 16 locations
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 9
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.